Abstract
Objectives Current estimates of the total number of cases of COVID-19 are largely based on previously-determined case fatality rates (CFRs). In this study, we aim to find an association between the Covid-19 number of cases / million inhabitants (M) and mortality rate (MR), and the association of Covid MR −19 and CFR. The background theory in this study is based on two factors: (1) There is no evidence that the CFR is fixed throughout time or place during an epidemic and (2) there is evidence that an increased viral load (density of infection) leads to more fatalities.
Study Design We chose 31 countries with testing coverage levels of > 400,0000 tests /M and populations greater than 1 million inhabitants.
Methods We used ANOVA regression analyses to test the associations.
Results There was a very highly significant correlation between MR and the total number of cases/ million population inhabitants(M) (P-value 0.0000).
The CRF changed with a change in the MR. A very high positive influence of the COVID-19 MR on the CFR (P-value = 0.0002).
Conclusions Increased number of cases per million inhabitants is associated with increased MR. Increased MR is associated with increased CFR. This finding might explain variable mortality rates that happened during this pandemic and possibly previous pandemics. This evidence will give us an idea of the behavior of epidemics in general.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I used publically available data.Patients were not involved
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
tareeffadhil{at}yahoo.com
Two tables were revised using the same original data. The methodology was revised to clarify results, findings, and conclusions.
Data Availability
data is available through supplementary attached file
